Altimmune Inc (ALT)
8.40
+0.35
(+4.35%)
USD |
NASDAQ |
Nov 21, 16:00
8.51
+0.11
(+1.31%)
After-Hours: 20:00
Altimmune Profit Margin (Quarterly): -456.9K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -456.9K% |
| June 30, 2024 | -492.8K% |
| March 31, 2024 | -487.9K% |
| December 31, 2023 | -85.52K% |
| September 30, 2023 | -5.71K% |
| June 30, 2023 | -267.7K% |
| March 31, 2023 | -95.59K% |
| December 31, 2022 | |
| September 30, 2022 | -1.18M% |
| June 30, 2022 | -251.3K% |
| March 31, 2022 | -60.72K% |
| December 31, 2021 | -729.0% |
| September 30, 2021 | -21.21K% |
| June 30, 2021 | -18.12K% |
| March 31, 2021 | -1.77K% |
| December 31, 2020 | -459.3% |
| September 30, 2020 | -604.8% |
| June 30, 2020 | -2.32K% |
| March 31, 2020 | -175.6% |
| December 31, 2019 | -711.5% |
| September 30, 2019 | -1.70K% |
| June 30, 2019 | -208.3% |
| March 31, 2019 | -70.96% |
| December 31, 2018 | -946.7% |
| September 30, 2018 | -89.25% |
| Date | Value |
|---|---|
| June 30, 2018 | -378.1% |
| March 31, 2018 | -117.9% |
| December 31, 2017 | -82.52% |
| September 30, 2017 | -112.1K% |
| June 30, 2017 | -62.99K% |
| March 31, 2017 | -92.73K% |
| December 31, 2016 | -1.27K% |
| September 30, 2016 | -97.11K% |
| June 30, 2016 | -1.02K% |
| March 31, 2016 | -122.0% |
| December 31, 2015 | -97.78% |
| September 30, 2015 | -114.6% |
| June 30, 2015 | -203.6% |
| March 31, 2015 | 20.70% |
| December 31, 2014 | -144.0% |
| September 30, 2014 | -480.9% |
| June 30, 2014 | -12.00% |
| March 31, 2014 | -60.35% |
| December 31, 2013 | -121.1% |
| September 30, 2013 | -113.1% |
| June 30, 2013 | -28.78% |
| March 31, 2013 | -32.61% |
| December 31, 2012 | -21.11% |
| September 30, 2012 | -3.19% |
| June 30, 2012 | -11.98% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.18M%
Minimum
Sep 2022
-175.6%
Maximum
Mar 2020
-180.3K%
Average
-21.21K%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Viking Therapeutics Inc | -- |
| Amgen Inc | 33.28% |
| Avid Bioservices Inc | -13.78% |
| NovaBay Pharmaceuticals Inc | -49.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -64.43% |
| Return on Assets | -58.37% |
| Return on Invested Capital | -64.43% |
| Operating Margin (Quarterly) | -495.3K% |
| Return on Net Operating Assets | -1.54K% |